FIELD: medicine.
SUBSTANCE: invention refers to medicine and pharmaceutics and concerns applications of biologically active agent of formula (1) 
to prepare a medicinal agent for treatment of the condition chosen from the group including insulin unresponsiveness syndrome, diabetes, hyperlipidemia, hypertensia, nephropathy, neuropathy, retinopathy, feet ulceration or diabetes associated cataracts, method of mammal treatment, pharmaceutical composition and biologically active agent containing compound of formula (1).
EFFECT: invention provides improved clinical effectiveness.
22 cl, 4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUND FOR TREATING METABOLIC DISORDERS | 2008 |
|
RU2521284C2 |
| COMPOUNDS FOR TREATMENT OF METABOLIC DISORDERS | 2006 |
|
RU2420276C2 |
| COMPOUNDS FOR METABOLIC DISORDER TREATMENT | 2004 |
|
RU2349584C2 |
| COMPOUNDS FOR TREATMENT OF METABOLIC DISEASES | 2002 |
|
RU2341513C2 |
| TETRAZOLE COMPOUNDS FOR REDUCING CONCENTRATION OF URIC ACID | 2009 |
|
RU2522458C2 |
| COMPOUNDS FOR TREATING METABOLIC DISEASES | 2008 |
|
RU2502723C2 |
| APPLICATION OF THIAZOLIDINEDIONES FOR PREVENTION OR ONSET POSTPONEMENT OF INSULIN-INDEPENDENT DIABETES MELLITUS (NIDDM) | 1994 |
|
RU2195282C2 |
| COMBINATED INHIBITORS OF FBP-ASE AND ANTIDIABETIC AGENTS FOR DIABETES TREATMENT | 2001 |
|
RU2328308C2 |
| METHOD FOR TREATMENT OF IMPAIRED GLUCOSE TOLERANCE | 2001 |
|
RU2281094C2 |
| PYRIDINE DERIVATIVES FOR TREATING METABOLIC DISORDERS ASSOCIATED WITH INSULIN RESISTANCE OR HYPERGLYCAEMIA | 2007 |
|
RU2448093C2 |
